在人类受试者中阻断抗体反应,这些受试者受到一种新的雪山病毒 (Inoculum) 的挑战
Makoto Ibaraki1, Lilin Lai2, Christopher Huerta3
1Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
概括
雪山病毒 (SMV) 的挑战引起了对血基组抗原 (HBGA) 阻断的抗体,感染个体在挑战后45天内观察到显著增加. 这些发现突显了SMV注射剂的有效性和阻断抗体的产生.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 诺罗病毒 (NoVs) 引起广泛的胃肠炎.
- 雪山病毒 (SMV) 是一种GII.2原型,用于人类挑战研究.
- 阻断抗体对于理解新型病毒病原和疫苗疗效至关重要,但针对SMV的具体数据有限.
研究的目的:
- 来自受SMV挑战的个体的血清样本中的封锁抗体的特征.
- 在挑战后检查阻塞抗体标位和SMV特异性IgG/IgA之间的相关性.
- 评估HBGA阻断抗体度与挑战后几天之间的关联.
主要方法:
- 来自33名SMV注射受试者的血清样本的二次数据分析.
- 阻断抗体,IgG和IgA水平的表征.
- 应用线性混合模型来分析抗体度的时间和感染状态.
主要成果:
- 75.7%的参与者在中小企业挑战之后感染了病毒.
- 从挑战后的第15天开始,感染者和未感染者之间观察到阻断抗体,IgA和IgG的显著差异.
- 在挑战后的第六天,在受感染的个体中发现了IgG,IgA和阻断抗体之间的显著相关性.
结论:
- 基因组抗原 (HBGA) 阻断抗体的几何平均标位 (GMT) 在SMV挑战后产生.
- 阻塞抗体在挑战后的45天内仍然可以检测到.
- 第二代SMV注射剂在引起免疫反应方面表现出高效.
更多相关视频
12:09Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
18.1K
06:34An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
36.0K
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Immune Response Against Viral Pathogens
776
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
776
